GlassScriptPhysician profile
Ramon Barcelona
NPI 1437157815
$1,189.95
in general payments reported to CMS, 2019-2025
15 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.00 · 2021: $157 · 2022: $142 · 2023: $359 · 2024: $281 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $880.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $879.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $450.82 | 2023-2025 | |
| Dexcom, INC. | $225.22 | 2022-2024 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $146.04 | 2020-2025 | Airsupra |
| Abbvie INC. | $69.43 | 2021-2024 | Vraylar |
| Genentech USA, INC. | $56.48 | 2021-2022 | |
| Glaxosmithkline, LLC. | $49.19 | 2022-2023 | Bexsero |
| Novo Nordisk INC | $46.49 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $29.26 | 2021-2023 | M-M-R II, Vaxneuvance, Rotateq |
| Alexion Pharmaceuticals, INC. | $26.33 | 2022-2023 | Strensiq |
| Astellas Pharma US INC | $18.24 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.89 | 2022 | |
| Exact Sciences Corporation | $14.17 | 2025 | Cologuard Collection Kit |
| Gilead Sciences, INC. | $14.00 | 2023 | |
| Abbott Laboratories | $13.92 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $12.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramon Barcelona listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.